Gelonghui May 2 | Cornerstone Pharmaceutical-B (02616.HK) announced that Mr. Kenneth Walton Hitchner III (“Mr. Hitchner”), a non-executive director of the company, increased his shareholding in the company. The company was informed by Mr. Hitchner that it used its own capital to purchase a total of 2,219,500 shares on the open market between April 9 and April 19, 2024, at an average purchase price of approximately HK$0.86. After the bank purchased the shares, Mr. Hitchner held a total of 2,613,500 shares, which is equivalent to approximately 0.20% of the company's total issued share capital at the date of this announcement.

Mr. Hitchner told the company that he is confident in the future prospects of the company, and that the increase in the company's shares represents his belief in the company's ability to maintain steady operation while achieving rapid growth in a complex and changing market environment, as well as unremitting support for the company's growth and development. Mr Hitchner did not rule out that it might step up its holdings in the company in due course. The board of directors believes that the increase in the company's shares by non-executive directors reflects Mr. Hitchner's confidence in the company's future business prospects.